Ophthalmic Products

      Ophthalmic Products

Alzapred Forte

    Alzapred Forte is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation. Loteprednol is less effective than prednisolone acetate 1% in two 28-day controlled clinical studies in acute anterior uveitis, where 72% of patients treated with Loteprednol experienced resolution of anterior chamber cells, compared to 87% of patients treated with prednisolone acetate 1%. The incidence of patients with clinically significant increases in IOP (>10 mmHg) was 1% with Alzapred Forte and 6% with prednisolone acetate 1%. Alzapred Forte should not be used in patients who require a more potent corticosteroid for this indication. Alzapred Forte is also indicated for the treatment of post-operative inflammation following ocular surgery.

    SHAKE VIGOROUSLY BEFORE USING.
    Steroid Responsive Disease Treatment:
    Apply one to two drops of Alzapred Forte into the conjunctival sac of the affected eye(s) four times daily. During the initial treatment within the first week, the dosing may be increased, up to 1 drop every hour, if necessary. Care should be taken not to discontinue therapy prematurely. If signs and symptoms fail to improve after two days, the patient should be re-evaluated (See PRECAUTIONS ). Post-Operative Inflammation :
    Apply one to two drops of Alzapred Forte into the conjunctival sac of the operated eye(s) four times daily beginning 24 hours after surgery and continuing throughout the first 2 weeks of the post-operative period.